Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Net Income	-105.8	-79.28	-46.51	-10.76	-7.27	-3.39
Depreciation & Amortization	2.94	2.3	0.71	0.32	0.28	0.21
Other Amortization	0.01	0.01	0.01	0	0.01	0.01
Loss (Gain) From Sale of Assets	0.03	0.03	0.02	0.31	-	0.01
Asset Writedown & Restructuring Costs	24.06	24.06	-	-	-	-
Loss (Gain) From Sale of Investments	-2.93	-0.61	-	-	-	-
Stock-Based Compensation	8.55	5.22	3.14	0.98	1.09	0.39
Other Operating Activities	-1.13	-2.06	-2.24	-0.22	0	0
Change in Accounts Receivable	0.15	1.05	0.2	0.28	0.41	0.03
Change in Inventory	-0.01	-	-	-2	-2.67	-0.27
Change in Accounts Payable	-12.05	1.89	1.57	0.69	0.24	0.08
Change in Unearned Revenue	-1.4	28	-	-	-	-
Change in Other Net Operating Assets	2.92	0.86	0.79	-0.03	0.18	0.1
Operating Cash Flow	-84.43	-18.29	-36.91	-10.4	-7.71	-2.84
Capital Expenditures	-22.29	-54.41	-1.07	-0.28	-0.27	-0.38
Sale of Property, Plant & Equipment	0.34	0.34	-	-	-	0
Cash Acquisitions	-	-	2.7	-	-	-
Investment in Securities	-103.83	-164.78	22.76	-22.69	-	-
Other Investing Activities	-0.13	-0.07	-0.02	-6.02	-0.02	-0.03
Investing Cash Flow	-125.91	-218.93	24.37	-28.99	-0.28	-0.41
Long-Term Debt Repaid	-	-0.05	-0.07	-	-	-
Net Debt Issued (Repaid)	-0.05	-0.05	-0.07	-	-	-
Issuance of Common Stock	-	277.19	0.92	0.03	0.06	64.69
Preferred Dividends Paid	-	-	-	-	-	-0.01
Dividends Paid	-	-	-	-	-	-0.01
Other Financing Activities	12.25	12.25	-0.07	-	-	-
Financing Cash Flow	10.66	289.39	0.79	0.03	0.06	64.68
Net Cash Flow	-199.68	52.16	-11.76	-39.36	-7.94	61.44
Free Cash Flow	-106.72	-72.71	-37.99	-10.68	-7.98	-3.22
Free Cash Flow Margin	-9927.53%	-5000.55%	-2648.88%	-197.28%	-	-32.01%
Free Cash Flow Per Share	-1.46	-1.13	-1.42	-0.75	-0.56	-0.31
Levered Free Cash Flow	-79.28	-83.66	-8.54	-	-2.73	-2.08
Unlevered Free Cash Flow	-79.13	-83.63	-8.49	-	-2.73	-2.08
Change in Working Capital	-10.4	31.8	2.56	-1.05	-1.85	-0.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q